Onyx @ Jefferies: Warner Biddle, CEO, Kyverna Therapeutics
Fresh momentum from Jefferies and a new $150 million non-dilutive financing has extended its runway into 2027.
Fresh momentum from Jefferies and a new $150 million non-dilutive financing has extended its runway into 2027.